Your browser doesn't support javascript.
loading
Adapting the HCT-CI Definitions for Children, Adolescents, and Young Adults with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Cell Transplantation.
Friend, Brian D; Broglie, Larisa; Logan, Brent R; Chhabra, Saurabh; Bupp, Caitrin; Schiller, Gary; Beitinjaneh, Amer; Perez, Miguel Angel Diaz; Guilcher, Gregory M T; Hashem, Hasan; Hildebrandt, Gerhard C; Krem, Maxwell M; Lazarus, Hillard M; Nishihori, Taiga; Nusrat, Roomi; Rotz, Seth J; Wirk, Baldeep; Wieduwilt, Matthew; Pasquini, Marcelo; Savani, Bipin N; Stadtmauer, Edward A; Sorror, Mohamed L; Thakar, Monica S.
Affiliation
  • Friend BD; Baylor College of Medicine Center for Cell and Gene Therapy, Houston, Texas.
  • Broglie L; CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; Division of Pediatric Hematology/Oncology/Blood and Marrow Transplant, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Logan BR; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, Wisconsin; CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Chhabra S; CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; Division of Hematology/Oncology, Department of Medicine, Mayo Clinic Arizona, Phoenix, Arizona. Electronic address: Chhabra.Saurabh@mayo.edu.
  • Bupp C; CIBMTR (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis, Minnesota.
  • Schiller G; Hematological Malignancy/Stem Cell Transplant Program, David Geffen School of Medicine at UCLA, Los Angeles, California.
  • Beitinjaneh A; Division of Transplantation and Cellular Therapy, University of Miami Hospital and Clinics, Sylvester Comprehensive Cancer Center, Miami, Florida.
  • Perez MAD; Department of Hematology/Oncology, Hospital Infantil Universitario Niño Jesus, Madrid, Spain.
  • Guilcher GMT; Section of Pediatric Oncology/Cellular Therapy, Alberta Children's Hospital, Departments of Oncology and Pediatrics, University of Calgary, Calgary, Alberta, Canada.
  • Hashem H; Division of Pediatric Hematology/Oncology and Bone Marrow Transplantation, King Hussein Cancer Center, Amman, Jordan.
  • Hildebrandt GC; Ellis Fischel Cancer Center, University of Missouri, Columbia, Colorado.
  • Krem MM; Kansas City VA Medical Center, Kansas City, Missouri.
  • Lazarus HM; University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio.
  • Nishihori T; Department of Blood & Marrow Transplant and Cellular Immunotherapy (BMT CI), Moffitt Cancer Center, Tampa, Florida.
  • Nusrat R; Unversity of Michigan, Ann Arbor, Michigan.
  • Rotz SJ; Department of Pediatric Hematology, Oncology, and Blood and Marrow Transplantation, Cleveland Clinic Children's Hospital, Cleveland, Ohio.
  • Wirk B; Bone Marrow Transplant Program, Penn State Cancer Institute, Hershey, Pennsylvania.
  • Wieduwilt M; Department of Medicine, University of Oklahoma, Stephenson Cancer Center, Oklahoma City, Oklahoma.
  • Pasquini M; CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Savani BN; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Stadtmauer EA; University of Pennsylvania Abramson Cancer Center, Philadelphia, Pennsylvania.
  • Sorror ML; Clinical Research Division, Fred Hutchinson Cancer Center, University of Washington, Seattle, Washington; Department of Medicine, University of Washington School of Medicine, Seattle, Washington.
  • Thakar MS; Clinical Research Division, Fred Hutchinson Cancer Center, University of Washington, Seattle, Washington; Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington.
Transplant Cell Ther ; 29(2): 123.e1-123.e10, 2023 02.
Article in En | MEDLINE | ID: mdl-36442769
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Hematologic Neoplasms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Child / Humans Language: En Journal: Transplant Cell Ther Year: 2023 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Hematologic Neoplasms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Child / Humans Language: En Journal: Transplant Cell Ther Year: 2023 Document type: Article Country of publication: